Pulsed methylprednisolone: MECOMBIN trial results


REPORT FROM THE 25th CONGRESS OF THE ECTRIMS – Dusseldorf, Germany, September 9-12, 2009  The results of the MECOMBIN trial of pulsed methylprednisolone plus intramuscular beta-interferon-1a indicate that the combination is not more effective in delaying the onset of disability progression, although improvements in relapse rate and functional scores were observed (Ravnborg et al. ECTRIMS 2009).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page